Highbury Group

Seattle-based multi-stage VC partnering with entrepreneurs creating transformative tech across industries

ActiveVenture Capital

Website LinkedIn

Updated: Jan 22, 2026 ·

About

Seattle-based multi-stage VC partnering with entrepreneurs creating transformative tech across industries

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Sep 1, 2025	Modern Animal	$46.0M Series D	—	Addition, Atreides Management, Bam Ventures, O.G. Tech Partners, Redline Capital, True Ventures, Upfront Ventures, Viola Ventures, Walden International, Peter Hunn
Jun 1, 2025	Emerald AI	$34.0M Seed	—	AI4ALL, Axiom Partners, Conviction Partners, Kleiner Perkins, Madrona Ventures, Kazuma Ieiri, Plug & Play Ventures, Radical Ventures, Akshay Kothari, Amjad Masad, Oliver Cameron
Mar 1, 2025	Layer Health	$21.0M Series A	—	Define Ventures, Flare Capital Partners, Anthony Philippakis, GV
Jan 1, 2025	FIRE1	$120.0M Series B	—	aMoon Fund, Polaris Partners, Section 32
Jan 1, 2025	Eleos Health	$60.0M Series C	—	Alex, Alpha Edison, Bond, Drive Capital, Eight Roads Ventures, Ensemble VC, F-Prime Capital Partners, ‎GreatPoint Ventures, Hamilton Lane, Erel Margalit, Yoav Tzruya, Maccabee Ventures, Menlo Ventures, Thylacine Capital, Uprising, VZVC, Anne Wojcicki
Aug 1, 2024	Fortera	$85.0M Series C	—	Khosla Ventures, VZVC, What If Ventures
Aug 1, 2024	Levels	$10.0M Series A	—	01 Advisors, AAF Management Ltd., AirAngels, Andreessen Horowitz, Backed VC, Basecamp Fund, Brainchild, CrunchFund, Founder Collective, Frst, IDInvest Partners, Incisive Ventures, Khosla Ventures, KW Angel Fund, Long Journey Ventures, Pioneer Square Labs, Redpoint Ventures, Shrug Capital, Stellar Capital, Supernode Ventures, Todd and Rahul's Angel Fund, VZVC, Wave Capital, What If Ventures, Bradley Horowitz, Brendan O'Driscoll, Mario Gabriele, Matteo Franceschetti, Matthew Dellavedova, Moshe Lifschitz, Scott Banister
May 1, 2024	Elegen	$35.0M Series B	—	Builders VC, KdT Ventures, Sofinnova Investments, VZVC, Wilbur-Ellis [Cavallo]
May 1, 2024	Polymarket	$25.0M Series A	—	Addition, American Express Ventures, Andreessen Horowitz, Base Partners, Bond, CapitalG, Company Capital, E1 Ventures, Founders Fund, General Catalyst, Graypes GmbH, North Island Ventures, Polychain Capital, SciFi VC, Henry Fertik, UpHonest Capital, Aaron Levie, Elon Musk, Fanny Surjana, Jean-Sébastien Wallez, Liam Casey, Matt Mazzeo, Michael Moritz, Pratik Kapoor, Richard Cooperstein, Stani Kulechov
Apr 1, 2024	Scheduler AI	$3.0M Seed	—	11 Tribes Ventures, Act One Ventures, Addition, Anthemis Group, Betaworks Ventures, Bonfire Ventures, BoxGroup, Browder Capital, Buckley Ventures, CapitalX, Coelius Capital, Composite Ventures, Crosscut Ventures, Kevin Ding, Drive Capital, Founders Fund, General Atlantic, Lytical Ventures, Matchstick Ventures, Scott Sandell, Pareto Holdings, Revolution Growth, SCOR Ventures, SignalFire, Springdale Ventures, The Hit Forge, Clark Landry, Daren Cotter, Jiake Liu, Lev Ekster, Ryan Wyatt, Sahil Lavingia, Scott Belsky
Feb 1, 2024	BioAge Labs	$170.0M Series D	—	F-Prime Capital Partners, Johnson & Johnson Innovation, Sofinnova Investments, Third Rock Ventures, Uprising, VZVC
Nov 1, 2023	Koya Medical	$30.0M Series C	—	Cota Capital, Khosla Ventures, OrbiMed, Pear VC, Tencent Holdings, WndrCo LLC, Chris Schaepe, David Chen, Farzad Nazem, Laszlo Bock
Sep 1, 2023	Mentra	$4.0M Seed	—	9Yards Capital, Acrew Capital, Brewer Lane Ventures, C2 Investment, Coatue, Collaborative Seed & Growth Partners, DNX Ventures, Drummond Road Capital, eFounders, Electric Capital, Energize Ventures, Felicis Ventures, FirstMark Capital, First Round Capital, Greylock, Index Ventures, LGF, Lightspeed Venture Partners, LombardStreet Ventures, Long Journey Ventures, New Stack Ventures, Operator Collective, Otherwise Fund, Sarah Smith Fund, Sherpalo Ventures, Shine Capital, The Hit Forge, Third Kind Ventures, Andrew Jones, Christian Reber, Elad Gil, J.D. Fagan, JD Ross, Karim Atiyeh, Matt Macinnis, Mike Vernal, Sam Corcos, Scott Belsky, Steven Alan, Thibaud Elziere
May 1, 2023	River	$35.0M Series B	—	Addition, American Express Ventures, Andreessen Horowitz, Base Partners, Bond, CapitalG, Company Capital, E1 Ventures, Founders Fund, General Catalyst, Graypes GmbH, SciFi VC, Henry Fertik, UpHonest Capital, Aaron Levie, Elon Musk, Fanny Surjana, Jean-Sébastien Wallez, Liam Casey, Matt Mazzeo, Michael Moritz, Pratik Kapoor, Richard Cooperstein
Mar 1, 2023	Humane	$100.0M Series C	—	Accel, Adverb Ventures, AME Cloud Ventures, Andreessen Horowitz, Chloe Sladden, Bono, Caffeinated Capital, Electric Capital, Footwork, General Catalyst, Hardware Club, Heretic Ventures, Jetstream, Kindred Ventures, LGF, Maveron, Menlo Ventures, Moxxie Ventures, Practical Venture Capital, Quiet Capital, REMUS Capital, Salesforce Ventures, SciFi VC, Sequoia Capital, South Park Commons, Tiger Global Management, Union Square Ventures, Unusual Ventures, Matt Garratt, Y Combinator, Aaron Levie, Ben Davenport, Bill Tai, Chung Ng, Drew Houston, Dylan Field, Gokul Rajaram, Jeffrey Lam, Joshua Schachter, Julia Hartz, Roy Rodenstein, Steve Aoki
Jan 1, 2023	Cymbal	$19.0M Seed	—	Act One Ventures, Addition, Anthemis Group, Betaworks Ventures, Bonfire Ventures, BoxGroup, Browder Capital, Buckley Ventures, CapitalX, Coelius Capital, Composite Ventures, Crosscut Ventures, Kevin Ding, Drive Capital, Founders Fund, General Atlantic, Kleiner Perkins, Lytical Ventures, Matchstick Ventures, Scott Sandell, Pareto Holdings, Revolution Growth, SCOR Ventures, SignalFire, Springdale Ventures, The Hit Forge, Clark Landry, Daren Cotter, Jiake Liu, Lev Ekster, Neil Hunt, Sahil Lavingia, Scott Belsky, Tom Steyer
Jan 1, 2023	Speakeasy	$7.0M Seed	—	Act One Ventures, Addition, Anthemis Group, Betaworks Ventures, Bonfire Ventures, BoxGroup, Browder Capital, Buckley Ventures, CapitalX, Coelius Capital, Composite Ventures, Crosscut Ventures, Kevin Ding, Drive Capital, Founders Fund, General Atlantic, Lytical Ventures, Matchstick Ventures, Scott Sandell, Pareto Holdings, Revolution Growth, SCOR Ventures, SignalFire, Springdale Ventures, The Hit Forge, Clark Landry, Daren Cotter, Jiake Liu, Lev Ekster, Ryan Wyatt, Sahil Lavingia, Scott Belsky
Oct 1, 2022	Scheduler AI	$1.0M Seed	—	11 Tribes Ventures, Act One Ventures, Addition, Anthemis Group, Betaworks Ventures, Bonfire Ventures, BoxGroup, Browder Capital, Buckley Ventures, CapitalX, Coelius Capital, Composite Ventures, Crosscut Ventures, Kevin Ding, Drive Capital, Founders Fund, General Atlantic, Lytical Ventures, Matchstick Ventures, Scott Sandell, Pareto Holdings, Revolution Growth, SCOR Ventures, SignalFire, Springdale Ventures, The Hit Forge, Clark Landry, Daren Cotter, Jiake Liu, Lev Ekster, Ryan Wyatt, Sahil Lavingia, Scott Belsky
Oct 1, 2022	Stairwell	$45.0M Series B	—	Accel, Andreessen Horowitz, Four Rivers Group, Gradient Ventures, Innovation Endeavors, Intel Capital, Kaszek Ventures, Menlo Ventures, Salesforce Ventures, Section 32, Sequoia Capital, Unusual Ventures, Matt Garratt, Gokul Rajaram, Nick Sinai
Oct 1, 2022	Start Left® Security	$3.0M Seed	—	Act One Ventures, Addition, Anthemis Group, Betaworks Ventures, Bonfire Ventures, BoxGroup, Browder Capital, Buckley Ventures, CapitalX, Coelius Capital, Composite Ventures, Crosscut Ventures, Kevin Ding, Drive Capital, Founders Fund, General Atlantic, Lytical Ventures, Matchstick Ventures, Scott Sandell, Pareto Holdings, Revolution Growth, SCOR Ventures, SignalFire, Springdale Ventures, The Hit Forge, Clark Landry, Daren Cotter, Jiake Liu, Lev Ekster, Ryan Wyatt, Sahil Lavingia, Scott Belsky
Aug 1, 2022	Alma	$130.0M Series D	—	CRV, Future Shape, Insight Partners, Motier Ventures, Optum Ventures, Picus Capital, Rainfall Ventures, Roosh Ventures, Silverton Partners, Tiger Global Management, Tusk Venture Partners, Upfront Ventures, Didier Valet, Ross Devor, Scott Belsky
Aug 1, 2022	Power Life Science	$7.0M Seed	—	Accomplice VC, Alumni Ventures, CRV, Aniq Kassam, Future Shape, Matrix, Night Capital, SignalFire, Silverton Partners, Susa Ventures, Tiger Global Management, Tusk Venture Partners, Upfront Ventures, Elliott Cohen, Sunil Paul, Travis May
Aug 1, 2022	Column	$30.0M Series A	—	20VC, AirAngels, Buckley Ventures, Coalition Operators, Kevin Ding, Earl Grey Capital, Innovation Endeavors, Lux Capital, Mantis VC, Pareto Holdings, Renegade Partners, Shasta Ventures, Slow Ventures, Trucks Venture Capital, Trust Fund, Volition Capital, Gen Isayama, Baron Davis, George Ruan, Julian Shapiro, Louis Beryl, Manik Gupta, Mathilde Collin, Melissa Tan, Ryan Tedder, Scott Belsky, Siqi Chen, Tyler Willis, Vindi Banga
Aug 1, 2022	VitaDAO	$500K Seed	—	2xN, Andreessen Horowitz, Angel investor, Catalio Capital, Haun Ventures, Pfizer Venture Investments, Ulu Ventures, What If Ventures, WndrCo LLC
Jul 1, 2022	BigHat Biosciences	$75.0M Series B	—	7wire Ventures, AlleyCorp, aMoon Fund, Andreessen Horowitz, B Capital Group, Curie.Bio, Define Ventures, General Catalyst, Kleiner Perkins, Operator Partners, Polaris Partners, Section 32, Thirty Five Ventures, Transformation Capital, UP.Partners

Financial History

Total Raised

N/A

Valuation

N/A

Leadership Team

Key people at Highbury Group.

Ling Wong

Managing Partner

Leadership Team

Key people at Highbury Group.

Ling Wong

Managing Partner

Deep Dive

High-Level Overview

Highbury Group is a Seattle-based multi-stage venture capital firm that partners with entrepreneurs building transformative technologies across various industries, with a strong emphasis on healthcare and life sciences. Founded by Dr. Ling Wong, the firm leverages deep scientific expertise to back startups that aim to create lasting impact through innovation. Its investment philosophy centers on supporting visionary founders who are developing breakthrough solutions that can improve human health and other critical sectors. Highbury Group plays a significant role in the startup ecosystem by providing not only capital but also strategic guidance, helping companies scale and achieve meaningful outcomes[1][3][5][6].

Origin Story

Highbury Group was founded in 2014 by Dr. Ling Wong, an MIT-trained chemical engineer and biologist with a Ph.D. from Harvard. Dr. Wong brings a unique blend of scientific rigor and entrepreneurial experience, having been involved in multiple billion-dollar companies and successful exits, including Anacor Pharmaceuticals (acquired by Pfizer for $5.2B) and Slack (acquired by Salesforce for $27.7B). The firm’s focus evolved from Dr. Wong’s passion for science-driven ventures that address complex health challenges and other transformative technologies. Early traction for Highbury Group came from its founder’s extensive network and track record in partnering with high-growth companies in healthcare and technology[3][4][5].

Core Differentiators

Unique Investment Model: Solo-GP fund led by Dr. Ling Wong, combining deep scientific expertise with venture capital acumen.
Network Strength: Access to a broad network of entrepreneurs, scientists, and industry leaders, including partnerships with over 15 companies valued at $1B+.
Track Record: Proven success in backing companies that have achieved significant exits and public listings.
Operating Support: Hands-on partnership approach, offering strategic guidance rooted in scientific and technical knowledge.
Sector Focus: Strong specialization in healthcare, healthcare IT, and life sciences, enabling informed investment decisions and value creation[1][3][4][5].

Role in the Broader Tech Landscape

Highbury Group rides the trend of science-driven innovation in healthcare and transformative technologies, a sector experiencing rapid growth due to advances in biotechnology, digital health, and data analytics. The timing is favorable given increasing global demand for novel healthcare solutions and the convergence of technology with life sciences. Market forces such as rising healthcare costs, aging populations, and the need for personalized medicine create a fertile environment for Highbury’s portfolio companies. By supporting early and multi-stage ventures, Highbury Group influences the broader ecosystem by accelerating the development and commercialization of breakthrough technologies that can reshape industries and improve human health[1][3][5].

Quick Take & Future Outlook

Looking ahead, Highbury Group is well-positioned to expand its influence by continuing to back cutting-edge startups at the intersection of science and technology. Emerging trends such as AI in healthcare, precision medicine, and sustainable technologies will likely shape its investment focus. The firm’s founder-driven, science-centric approach provides a competitive edge in identifying and nurturing high-potential ventures. As the innovation landscape evolves, Highbury Group’s role as a strategic partner to entrepreneurs will deepen, potentially leading to more transformative breakthroughs and significant contributions to global health and technology sectors[3][5][6].

Sources

High-Level Overview

Origin Story

Core Differentiators

Unique Investment Model: Solo-GP fund led by Dr. Ling Wong, combining deep scientific expertise with venture capital acumen.
Network Strength: Access to a broad network of entrepreneurs, scientists, and industry leaders, including partnerships with over 15 companies valued at $1B+.
Track Record: Proven success in backing companies that have achieved significant exits and public listings.
Operating Support: Hands-on partnership approach, offering strategic guidance rooted in scientific and technical knowledge.
Sector Focus: Strong specialization in healthcare, healthcare IT, and life sciences, enabling informed investment decisions and value creation[1][3][4][5].